Jefferies raises AxoGen target price to $60 from $55
AXGN•Jefferies raised its target price for AxoGen to $60 from $55.
Related News
JP Morgan initiates Palantir coverage with overweight rating, $262 price target
PLTR•
Q2 Holdings Inc: Raymond James raises target price to $80 from $75
QTWO•
AI-related investment, consumers likely boosted US economic growth in third quarter
SPY•
Primerica: Middle-income purchasing power falls in September as energy costs rise
PRI•
Teck Q3 2026 adjusted profit attributable to shareholders more than doubles to CAD 923 million
TECK•